Effect of preoperative chemotherapy on the outcome of surgical treatment of vertebral tuberculosis: retrospective analysis of 434 cases

Arch Orthop Trauma Surg. 2001;121(1-2):65-6. doi: 10.1007/s004020000163.

Abstract

A retrospective analysis of 434 patients with vertebral tuberculosis who were treated surgically was performed with special reference to the preoperative duration of chemotherapy. Of these, 376 underwent 4 weeks of a chemotherapy regimen with isoniazid, rifampin and ethamburol, and in 2 re-activation of the disease was observed. The remaining 58 underwent operation for neurological impairment with 6-18 h of the same chemotherapy regimen, and in no case did re-activation occur. These results suggest a shorter duration of chemotherapy may be utilised in all patients undergoing surgical treatment for vertebral tuberculosis, providing a thorough debridement is performed, leaving no necrotic or infected tissue behind.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antitubercular Agents / therapeutic use*
  • Child
  • Combined Modality Therapy
  • Debridement / methods*
  • Drug Therapy, Combination
  • Ethambutol / therapeutic use*
  • Female
  • Humans
  • Isoniazid / therapeutic use*
  • Male
  • Middle Aged
  • Patient Selection
  • Premedication / methods*
  • Preoperative Care / methods*
  • Recurrence
  • Retrospective Studies
  • Rifampin / therapeutic use*
  • Time Factors
  • Treatment Outcome
  • Tuberculosis, Spinal / diagnosis
  • Tuberculosis, Spinal / drug therapy*
  • Tuberculosis, Spinal / surgery*

Substances

  • Antitubercular Agents
  • Ethambutol
  • Isoniazid
  • Rifampin